Sequana Therapeutics Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $166M

Sequana Therapeutics General Information

Description

Operator of a therapeutics company intended to develop proprietary gene therapy products. The company's products are developed using a gene discovery technology, enabling medical researchers to facilitate relatively rapid isolation and characterization of disease genes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 11099 North Torrey Pines Road
  • Suite 160
  • San Diego, CA 92037
  • United States
+1 (619)
Primary Industry
Biotechnology
Corporate Office
  • 11099 North Torrey Pines Road
  • Suite 160
  • San Diego, CA 92037
  • United States
+1 (619)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sequana Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 09-Jan-1998 $166M Completed Clinical Trials - General
1. Early Stage VC Completed Clinical Trials - General
To view Sequana Therapeutics’s complete valuation and funding history, request access »

Sequana Therapeutics Patents

Sequana Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-6100058-A Nucleic acid encoding a mammalian protein having specific amino acid sequence and involved in abnormal growth control; anticarcinogenic agents; for identifying homologous or related genes; gene therapy; mapping of protein regions Inactive 12-Aug-1997
US-5705380-A Identification of a gene encoding tulp2, a retina specific protein Inactive 04-Sep-1996
US-5686598-A Genes associated with retinal dystrophies Inactive 22-Aug-1996
WO-1997038004-A1 Gene family associated with neurosensory defects Inactive 10-Apr-1996
US-5776762-A Isolated cells and nucleic acids Inactive 10-Apr-1996 C07K14/47
To view Sequana Therapeutics’s complete patent history, request access »

Sequana Therapeutics Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Avalon Ventures Venture Capital Minority
Morgenthaler Venture Capital Minority
New Enterprise Associates Venture Capital Minority
New Leaf Venture Venture Capital Minority
Roche Venture Fund Corporate Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Sequana Therapeutics Investments (1)

Sequana Therapeutics’s most recent deal was a Later Stage VC with Aurora Biosciences for . The deal was made on 02-May-1996.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Aurora Biosciences 02-May-1996 Later Stage VC Drug Discovery
To view Sequana Therapeutics’s complete investments history, request access »

Sequana Therapeutics FAQs

  • When was Sequana Therapeutics founded?

    Sequana Therapeutics was founded in 1993.

  • Where is Sequana Therapeutics headquartered?

    Sequana Therapeutics is headquartered in San Diego, CA.

  • What industry is Sequana Therapeutics in?

    Sequana Therapeutics’s primary industry is Biotechnology.

  • Is Sequana Therapeutics a private or public company?

    Sequana Therapeutics is a Private company.

  • What is the current valuation of Sequana Therapeutics?

    The current valuation of Sequana Therapeutics is .

  • What is Sequana Therapeutics’s current revenue?

    The current revenue for Sequana Therapeutics is .

  • Who are Sequana Therapeutics’s investors?

    Avalon Ventures, Morgenthaler, New Enterprise Associates, New Leaf Venture, and Roche Venture Fund are 5 of 6 investors who have invested in Sequana Therapeutics.

  • When was Sequana Therapeutics acquired?

    Sequana Therapeutics was acquired on 09-Jan-1998.

  • Who acquired Sequana Therapeutics?

    Sequana Therapeutics was acquired by AXYS Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process